Literature DB >> 22873203

Activation of diverse signaling pathways by ex-vivo delivery of multiple cytokines for myocardial repair.

Mikhail Konoplyannikov1, Khawaja Husnain Haider, Vien Khach Lai, Rafeeq P H Ahmed, Shujia Jiang, Muhammad Ashraf.   

Abstract

We tested the hypothesis that simultaneous transgenic overexpression of a select quartet of growth factors activates diverse signaling pathways for mobilization and participation of various stem/progenitor cells for cardiogenesis in the infarcted heart. Human insulin growth factor-1 (IGF-1), vascular endothelial growth factor (VEGF), stromal cell-derived factor-1 (SDF-1a), and hepatocyte growth factor (HGF) plasmids were synthesized and transfected into skeletal myoblasts (SM) from young male wild-type or transgenic rats expressing green fluorescent protein (GFP). Overexpression of growth factors in transfected SM ((Trans)SM) was confirmed by reverse transcription polymerase chain reaction, western blotting, and fluorescence immunostaining. Using our custom-made growth factor array and western blotting, multiple angiogenic and prosurvival factors were detected in (Trans)SM, including secreted frizzled related protein-1,2,4,5, matrix metalloproteinases-3 and 9, connexin-43, netrin-1, Nos-2, Wnt-3, Akt, MAPK42/44, Stat3, nuclear factor kappa B (NFκB), hypoxia-inducible factor 1 (HIF-1α), and protein kinase C (PKC). The conditioned medium (CM) from (Trans)SM was cytoprotective for cardiomyocytes following H(2)O(2) treatment [P<0.01 vs. CM from native SM ((Nat)SM)], promoted a higher transwell migration of human umbilical cord vein endothelial cells (223.3±1.8, P<0.01) and in vitro tube formation (47.8±1.9, P<0.01). Intramyocardial transplantation of 1.5×10(6) (Trans)SM (group-3) in a rat model of acute myocardial infarction induced extensive mobilization of cMet(+), ckit(+), ckit(+)/GATA(4+), CXCR4(+), CD44(+), CD31(+), and CD59(+) cells into the infarcted heart on day 7 and improved integration of (Trans)SM in the heart compared to (Nat)SM (group 2) (P<0.05). Extensive neomyogenesis and angiogenesis in group-3 (P<0.01 vs. group-2), with resultant attenuation of infarct size (P<0.01 vs. group-2) and improvement in global heart function (P<0.01 vs. group-2) was observed at 8 weeks. In conclusion, simultaneous activation of diverse signaling pathways by overexpression of multiple growth factors caused massive mobilization and homing of stem/progenitor cells from peripheral circulation, the bone marrow, and the heart for accelerated repair of the infarcted myocardium.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22873203      PMCID: PMC3545358          DOI: 10.1089/scd.2011.0575

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  44 in total

Review 1.  Secreted Frizzled-related proteins: searching for relationships and patterns.

Authors:  Steve E Jones; Catherine Jomary
Journal:  Bioessays       Date:  2002-09       Impact factor: 4.345

2.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors:  Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

3.  Cellular cardiomyoplasty improves diastolic properties of injured heart.

Authors:  B Z Atkins; M T Hueman; J Meuchel; K A Hutcheson; D D Glower; D A Taylor
Journal:  J Surg Res       Date:  1999-08       Impact factor: 2.192

4.  Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function.

Authors:  Buddhadeb Dawn; Adam B Stein; Konrad Urbanek; Marcello Rota; Brian Whang; Raffaella Rastaldo; Daniele Torella; Xian-Liang Tang; Arash Rezazadeh; Jan Kajstura; Annarosa Leri; Greg Hunt; Jai Varma; Sumanth D Prabhu; Piero Anversa; Roberto Bolli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-25       Impact factor: 11.205

5.  Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion.

Authors:  Jan Kajstura; Marcello Rota; Brian Whang; Stefano Cascapera; Toru Hosoda; Claudia Bearzi; Daria Nurzynska; Hideko Kasahara; Elias Zias; Massimiliano Bonafé; Bernardo Nadal-Ginard; Daniele Torella; Angelo Nascimbene; Federico Quaini; Konrad Urbanek; Annarosa Leri; Piero Anversa
Journal:  Circ Res       Date:  2004-11-29       Impact factor: 17.367

6.  Hepatocyte growth factor-transfected skeletal myoblasts to limit the development of postinfarction heart failure.

Authors:  Annika Poppe; Peter Golsong; Britta Blumenthal; Robert von Wattenwyl; Philipp Blanke; Friedhelm Beyersdorf; Christian Schlensak; Matthias Siepe
Journal:  Artif Organs       Date:  2011-09-07       Impact factor: 3.094

Review 7.  Complex role of matrix metalloproteinases in angiogenesis.

Authors:  Q X Sang
Journal:  Cell Res       Date:  1998-09       Impact factor: 25.617

8.  Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.

Authors:  D A Taylor; B Z Atkins; P Hungspreugs; T R Jones; M C Reedy; K A Hutcheson; D D Glower; W E Kraus
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

9.  Evidence for fusion between cardiac and skeletal muscle cells.

Authors:  Hans Reinecke; Elina Minami; Veronica Poppa; Charles E Murry
Journal:  Circ Res       Date:  2004-03-04       Impact factor: 17.367

10.  Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

Authors:  Arman T Askari; Samuel Unzek; Zoran B Popovic; Corey K Goldman; Farhad Forudi; Matthew Kiedrowski; Aleksandr Rovner; Stephen G Ellis; James D Thomas; Paul E DiCorleto; Eric J Topol; Marc S Penn
Journal:  Lancet       Date:  2003-08-30       Impact factor: 79.321

View more
  14 in total

Review 1.  Making it stick: chasing the optimal stem cells for cardiac regeneration.

Authors:  Pearl Quijada; Mark A Sussman
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-11

2.  Stem cell secretome-rich nanoclay hydrogel: a dual action therapy for cardiovascular regeneration.

Authors:  Renae Waters; Settimio Pacelli; Ryan Maloney; Indrani Medhi; Rafeeq P H Ahmed; Arghya Paul
Journal:  Nanoscale       Date:  2016-04-14       Impact factor: 7.790

Review 3.  Vascular endothelial growth factor in heart failure.

Authors:  Ziad Taimeh; John Loughran; Emma J Birks; Roberto Bolli
Journal:  Nat Rev Cardiol       Date:  2013-07-16       Impact factor: 32.419

4.  Fibrin patch-based insulin-like growth factor-1 gene-modified stem cell transplantation repairs ischemic myocardium.

Authors:  Jun Li; Kai Zhu; Shan Yang; Yulin Wang; Changfa Guo; Kanhua Yin; Chunsheng Wang; Hao Lai
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-11

5.  The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activity.

Authors:  Miriam Bobadilla; Neira Sainz; Gloria Abizanda; Josune Orbe; José Antonio Rodriguez; José Antonio Páramo; Felipe Prósper; Ana Pérez-Ruiz
Journal:  Stem Cells Dev       Date:  2014-03-14       Impact factor: 3.272

6.  Sphingosine 1-phosphate elicits RhoA-dependent proliferation and MRTF-A mediated gene induction in CPCs.

Authors:  Alessandra Castaldi; Gino P Chesini; Amy E Taylor; Mark A Sussman; Joan Heller Brown; Nicole H Purcell
Journal:  Cell Signal       Date:  2016-04-14       Impact factor: 4.315

7.  G-CSF displays restricted ability to promote Sca-1(+) cardiac stem cell proliferation in vitro.

Authors:  Haijian Luo; Giulio Bassi; Maddalena Tessari; Zhenyu Yang; Giuseppe Faggian
Journal:  Mol Cell Biochem       Date:  2014-08-27       Impact factor: 3.396

Review 8.  The road ahead: working towards effective clinical translation of myocardial gene therapies.

Authors:  Michael G Katz; Anthony S Fargnoli; Richard D Williams; Charles R Bridges
Journal:  Ther Deliv       Date:  2014-01

9.  Cardiosphere-derived cell sheet primed with hypoxia improves left ventricular function of chronically infarcted heart.

Authors:  Tohru Hosoyama; Makoto Samura; Tomoaki Kudo; Arata Nishimoto; Koji Ueno; Tomoaki Murata; Takashi Ohama; Koichi Sato; Akihito Mikamo; Koichi Yoshimura; Tao-Sheng Li; Kimikazu Hamano
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

10.  Human vasculogenic cells form functional blood vessels and mitigate adverse remodeling after ischemia reperfusion injury in rats.

Authors:  Kyu-Tae Kang; Matthew Coggins; Chunyang Xiao; Anthony Rosenzweig; Joyce Bischoff
Journal:  Angiogenesis       Date:  2013-05-12       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.